RankAlpha logo
Back to Rankings

LYEL

Lyell ImmunopharmaF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LYEL vs peer average
18/100
LYEL vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · D 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PRLD is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $312.61M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPRLDPrelude Therapeutics
LYEL
Lyell Immunopharma
PRLD
Prelude Therapeutics
Grade
F
D
Momentum
7
76
Value
41
41
Sentiment
-
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs PRLD

LYEL / PRLD
Grade Position
Below peers
LYEL vs. peer average (F vs. C)
18/100
Momentum
7
PRLD
Value
41
LYEL
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LYEL
1
PRLD
Prelude Therapeutics Inc Common
D
40/100
-1
2
ORGO
Organogenesis Holdings Inc Class A Common
D
40/100
-1
3
ZNTL
Zentalis Pharmaceuticals Inc Common
B
80/100
-3
4
LAB
Standard BioTools Inc Common
D
40/100
-1
5
VNDA
Vanda Pharmaceuticals Inc Common
D
40/100
-1
PRLD is the first peer returned for this comparison set.